JP2017063898A - Medicine volatilizing device - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a medicine volatilizing device of a type that sucks a medicine through a liquid absorption wick and facilitates exchange of a medicine container.SOLUTION: A medicine volatilizing device according to the present invention includes a medicine container that has an opening in an upper part and in which a liquid medicine is accommodated, a liquid absorption wick inserted into the opening of the medicine container, a supporter that supports the medicine container and is attached to an object to be attached, and a cover member that is detachably attached to the support and covers at least the liquid absorption wick. The cover member is constituted to be removed from the support by sliding in a direction not toward the object to be attached.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a chemical volatilizer.

  Conventionally, various forms of drug volatilizers have been proposed in which drugs such as fragrances are volatilized. Among them, a chemical volatilizer used in a place where vibration occurs, for example, in a vehicle, has been proposed. However, such a chemical volatilizer has a problem that a liquid chemical contained therein is spilled. For this reason, as a chemical volatilizer used in a vehicle, a gel type that does not use a liquid chemical or a membrane type that does not easily leak even by vibrations is often used. The membrane type is a type in which a gas-permeable membrane is used and a chemical volatilized through the membrane is released to the outside (for example, Patent Document 1).

JP 2014-94619 A

  However, the membrane type has a problem that the drugs that can be used are limited. For example, when used in a high-temperature environment, only chemicals that would volatilize in a short period of time could be used. Therefore, the following chemical volatilizers can be considered when using chemicals that can be used in various environments regardless of temperature. That is, a drug volatilizer of a type that supports a drug container on a support attached to an object to be attached, sucks the drug contained in the drug container with a liquid absorbent core, and releases the volatilized drug to the outside can be considered. At this time, it is necessary to provide a cover member so that the liquid absorption core does not come into contact with the outside. When the medicine is used up, it is necessary to remove the cover member and replace the medicine container.

  The present invention has been made to solve this problem, and provides a drug volatilizer that sucks a drug by a liquid absorption core and can easily replace a drug container. The purpose is to do.

  The drug volatilizer according to the present invention has an opening in the upper part, a drug container in which a liquid drug is accommodated, a liquid absorption core inserted into the opening of the drug container, the drug container, and an attachment target A support member attached to the object, and a cover member that is detachably attached to the support member and covers at least the liquid absorption core, and the cover member slides in a direction not facing the attachment object. Therefore, it is configured to be removed from the support.

  According to this structure, it is comprised so that a cover member may be removed from the said support body by sliding in the direction which does not go to the said attachment target object. Therefore, the cover member can be removed while the support is attached to the attachment object. When the cover member is removed, the medicine container into which the liquid absorption core is inserted can be removed from the support, so that the medicine container can be easily replaced while the support is attached to the attachment object.

  The direction in which the cover member slides is not particularly limited as long as it does not face the object to be attached. For example, the direction can be as follows. That is, in the medicine volatilizer, the medicine container can be attached to the support on the side opposite to the attachment object across the support, and the direction from the attachment object to the medicine container Can be configured such that the cover member slides in an orthogonal direction.

  More specifically, in the drug volatilizer, the cover member can be formed to cover at least a part of the liquid absorbent core and the drug container, and slides upward to support the support. Can be configured to leave.

  In the drug volatilizer, the support may include a holding unit that holds the drug container from outside in the radial direction with respect to the axial direction of the opening.

  According to this configuration, since the medicine container that contains the medicine is held on the support so as to be sandwiched from outside in the radial direction with respect to the axial direction of the opening, the medicine container vibrates in the radial direction, that is, in the lateral direction. Even if it receives, it can prevent that a chemical | medical agent container detaches | leaves from a support body. As a result, it is possible to prevent the medicine from spilling from the medicine container.

  In the drug volatilizer, the holding unit may be configured to hold any position of the drug container. For example, the drug container has a neck part in which the opening is formed and an outer shape that is larger than the neck part. A main body portion to which the neck portion is coupled, and the holding portion can be configured to hold the neck portion.

  At this time, a protrusion can be formed on the outer peripheral surface of the neck, and the holding portion can be engaged with a gap between the protrusion and the main body. By doing so, since the movement of the drug container in the axial direction is restricted, it is possible to prevent the drug container from being detached from the support body even when the drug container receives vibration in the axial direction, that is, the vertical direction.

  In the medicine volatilizer, the main body portion includes a first part connected to the neck part, and a second part connected to a lower end part of the first part and having a larger outer shape than the first part. Can do.

  According to this configuration, the volume of the medicine container can be increased without increasing the main body portion in the height direction.

  In the drug volatilizer, the second part of the drug container can be attached to the support so as to protrude from the lower side of the cover member.

  If it does in this way, since it arrange | positions so that a chemical | medical agent container may protrude from the lower side of a cover member, the bottom part vicinity of a chemical | medical agent container can be exposed from a cover member. Thereby, the remaining amount of the medicine can be visually recognized until the medicine is used up.

  In the chemical volatilizer, the support and the cover member can form at least an internal space in which the liquid absorbent core is accommodated, and at least one of the cover member and the support communicates with the internal space. At least one vent can be formed.

  With this configuration, the chemical volatilized from the liquid absorbent core can be released to the outside of the cover member through the vent hole.

  In the chemical volatilizer, a plurality of the vent holes can be formed, and at least one of the vent holes can be formed at a position facing the attachment object in the support.

  According to this configuration, for example, when the object to be attached is one that discharges air like an air conditioner of an automobile, the air can flow into the internal space from the vent hole. And since this air is discharge | released outside from another ventilation hole, the chemical | medical agent volatilized from the liquid absorption core can be carried on the inflowed air, and can be discharge | released outside the cover member. Therefore, the medicine can be released into a wider space.

  According to the drug volatilizer according to the present invention, the drug container can be easily replaced.

It is a perspective view of the chemical volatilization device concerning one embodiment of the present invention. It is a front view of FIG. It is a side view of FIG. It is the perspective view which looked at the chemical volatilizer of FIG. 1 from back. It is the sectional view on the AA line of FIG. It is a perspective view of the chemical | medical agent container in the chemical volatilizer of FIG. It is a front view of the chemical | medical agent container of FIG. FIG. 8 is a plan view of FIG. 7. FIG. 7 is a front view showing a state where a cap is attached in the medicine container of FIG. 6. It is a perspective view of the liquid absorption core in the chemical volatilizer of FIG. It is a front view of the support body in the chemical volatilizer of FIG. It is a top view of FIG. FIG. 12 is a bottom view of FIG. 11. FIG. 12 is a rear view of FIG. 11. It is a right view of FIG. It is a side view which shows attachment to the support body of a chemical | medical agent container. It is a side view which shows attachment to the support body of a chemical | medical agent container. It is a perspective view of a support body in the state where a medicine container was attached. It is a front view of the cover member in the chemical volatilizer of FIG. FIG. 20 is a bottom view of FIG. 19. FIG. 20 is a rear view of FIG. 19. It is a rear view which shows attachment of the cover member with respect to a support body. It is a front view which shows attachment of the cover member with respect to a support body. It is a bottom view which shows the state in which the cover member was attached to the support body. It is a front view which shows the state by which the chemical | medical agent container, the support body, and the cover member were assembled. It is a side view of the fixing member in the chemical volatilizer of FIG.

  Hereinafter, one embodiment of a chemical volatilizer according to the present invention will be described with reference to the drawings. In the following, for convenience of explanation, the left side of FIG. 3 is referred to as the front side or the front side, and the right side is referred to as the back side or the rear side. 2 is referred to as the width direction or the left-right direction, and the up-down direction in FIG. 2 is referred to as the up-down direction. The other drawings will be described according to this direction. However, these directions do not limit the present invention.

  1 is a perspective view of a drug volatilizer according to the present embodiment, FIG. 2 is a front view of FIG. 1, FIG. 3 is a side view of FIG. 1, FIG. 4 is a perspective view of the drug volatilizer as viewed from the rear, and FIG. It is the sectional view on the AA line of FIG. As shown in FIGS. 1 to 5, a drug volatilizer according to this embodiment includes a drug container 1 in which a liquid drug is accommodated, and a liquid absorbent core 2 that is inserted into the drug container 1 and impregnated with the drug (see FIG. 1). 5), a support 3 that supports the medicine container 1, a cover member 4 that covers the medicine container 1, and a fixing member 5 for attaching the support 3 to an attachment object. Hereinafter, each of these members will be described in detail.

<1. Drug container>
6 is a perspective view of the drug container, FIG. 7 is a front view of the drug container, FIG. 8 is a plan view of FIG. 7, and FIG. 9 is a front view of the drug container with a cap attached. As shown in FIGS. 5 to 9, the drug container 1 according to the present embodiment includes a rectangular parallelepiped main body portion 11 and a neck portion 12 connected to the upper end of the main body portion 11. Is formed. The main body 11 is formed such that the left-right direction is longer than the front-rear direction, and a liquid medicine is accommodated in the internal space. Further, the main body 11 includes a first part 111 connected to the neck part 12 and a second part 112 connected to the lower end part of the first part 111. Both the first part 111 and the second part 112 are formed in a rectangular parallelepiped shape. However, the second part 112 is slightly larger than the outer shape of the first part 111, and the first part 111 and the second part 112 are arranged in the left-right direction and the front-rear direction. It is formed to bulge from the lower end. Thereby, a step 113 is formed at the boundary between the first part 111 and the second part 112.

  The neck portion 12 is formed in a cylindrical shape having an opening 121 at the upper end, and is connected to the upper end of the main body portion 11. On the outer peripheral surface of the neck 12, an annular protrusion 13 is formed at a position close to the upper surface 115 of the main body 11, and a holding portion, which will be described later, is formed in a gap between the protrusion 13 and the upper surface 115. Be placed. A spiral male screw 14 is formed on the outer peripheral surface of the neck 12 above the protrusion 13. The male screw 14 is adapted to be screwed into the female screw of the cap 15 shown in FIG. That is, a cap 15 is attached to the neck portion 12 and is removed during use.

  Further, as shown in FIG. 8, the inner wall surface of the neck portion 12 is formed in a circular shape in plan view, but grooves 122 are formed on the front side and the rear side. These grooves 122 extend in the vertical direction from the opening 121 of the neck 12 to the internal space of the main body 11, and form a gap with the outer peripheral surface of the liquid absorbent core 2.

  The drug container 1 as described above can be formed of various materials, but can be formed of a resin material. In this case, for example, those formed in a state of being divided in the vicinity of the center in the front-rear direction can be bonded together or molded by a blow method (for example, an injection blow method or a direct blow method). Among the blow methods, in particular, when the drug container 1 is formed by the direct blow method, a cylindrical parison is used, the parison is squeezed with two molds, and then the drug container 1 is injected while injecting air into the parison Integrally molded.

  Moreover, it is preferable to form the medicine container 1 with a transparent or translucent material so that the medicine inside can be visually recognized. As a liquid medicine accommodated in the medicine container 1, various kinds such as a known fragrance liquid, deodorant liquid, and aroma oil can be used depending on the application.

<2. Mounting to liquid core and drug container>
Next, attachment to the liquid absorbent core 2 and the drug container 1 will be described with reference to FIG. As shown in FIG. 10, the liquid absorption core 2 is formed in a columnar shape, and a groove 21 having a V-shaped cross section extending in the axial direction is formed on the outer peripheral surface. The groove 21 is formed from the upper end to the lower end of the liquid absorbent core 2.

  The material which comprises the liquid absorption core 2 will not be specifically limited if it can absorb a chemical | medical agent and volatilize a chemical | medical agent from the part which protrudes from the neck part 12 to the exterior. For example, various materials such as a resin material such as polyethylene, paper, and cloth can be used.

  As shown in FIG. 7, the liquid absorption core 2 is inserted from the opening 121 of the neck portion 12 of the medicine container 1 and arranged so as to be in contact with the bottom surface of the internal space of the main body portion 11. At this time, the upper end portion of the liquid absorbent core 2 protrudes upward from the opening 121 of the neck portion 12. Further, since the outer diameter of the liquid absorbent core 2 is substantially the same as the inner diameter of the opening 121 of the neck portion 12, the liquid absorbent core 2 abuts on the inner peripheral surface of the neck portion 12, and the standing state is maintained. However, as described above, since the groove 21 is formed on the outer peripheral surface of the liquid absorbent core 2 and the groove 122 is also formed on the inner wall surface of the neck portion 12, the outer peripheral surface of the liquid absorbent core 2 and the neck portion 12. A gap is formed between the inner wall surface by the grooves 21 and 122, and this gap serves as an air flow path that communicates the internal space of the main body 11 with the outside. This flow path operates as follows. For example, when the drug container 1 is used in a high temperature environment and the internal pressure of the drug container 1 increases, the air in the drug container 1 is discharged to the outside through the gaps 21 and 122. On the other hand, if such a gap is not provided, the drug may be excessively pushed out through the liquid absorbent core 2 when the internal pressure rises.

<3. Support>
Next, the support 3 will be described with reference to FIGS. 11 is a front view of the support, FIG. 12 is a plan view of FIG. 11, FIG. 13 is a bottom view of FIG. 11, FIG. 14 is a rear view of FIG.

  As shown in FIGS. 11 to 15, the support body 3 is provided on the front surface of the support body 31 formed in a plate shape with a rectangular shape in front view, and holds the neck 12 of the drug container 1. Holding part 32. Further, side walls 33 projecting forward are provided on both sides of the support body 31, and an upper wall 34 projecting forward is formed at the upper end of the support body 31. Further, a rectangular attachment portion 35 that protrudes toward the back surface is formed at the center of the support body 31. Hereinafter, each member will be described.

  First, the holding portion 32 is provided slightly below the center of the support body 31 in the vertical direction. Specifically, a pair of holding pieces 321a and 321b formed in a plate shape are provided, and these holding pieces 321 extend forward. These holding pieces 321 are arranged with a gap in the center in the left-right direction, and the neck 12 of the drug container 1 is held in this gap. More specifically, the gap between the holding pieces 321a and 321b is formed in a circular shape in plan view along the outer peripheral surface of the neck portion 12, but the gap between the front end portions of the holding pieces 321a and 321b is It is narrower than the diameter of the neck 12. As a result, the neck 12 is prevented from coming off.

  Next, the side wall 33 will be described. Here, since the side walls 33 are bilaterally symmetric, the right side wall 33 in FIG. 11 will be described below. As shown in FIG. 15, the side wall 33 has an upper edge portion 331 that protrudes forward from the vicinity of the upper end of the support body 31, and a lower edge along the side edge of the support body 31 from the rear end portion of the upper edge portion 331. An extending portion 332 that extends, and is formed in an L shape as a whole. The extending part 332 extends from the vicinity of the upper end of the support body 31 to the vicinity of the holding part 32. Further, an L-shaped rail 333 is formed along the lower edge of the upper edge portion 331 and the front edge portion of the extending portion 332 so as to protrude outward (right side in FIG. 11). Furthermore, a protrusion 334 that protrudes upward from the top of the rail 333 is formed on the outer surface of the upper edge 331.

  Next, the upper wall 34 will be described. The upper wall 34 is formed in a rectangular shape in plan view so as to connect the upper ends of the side walls 33, and protrudes forward from the support body 31 with substantially the same protruding length as the extending portion 332 of the side wall 33. . A pair of support pieces 36 protrudes forward from the front edge of the upper wall 34. Each support piece 36 protrudes forward of the side wall 33 with substantially the same length as the holding portion 32.

  Next, the attachment part 35 will be described. As shown in FIG. 14, a through hole 351 is formed at the center of the attachment portion 35, and a notch 352 opened downward is formed so as to communicate with the through hole 351. A shaft portion 511 of the fixing member 5 to be described later is fitted into the through hole 351 through a notch 352. A plurality of vent holes 316 penetrating the support body 31 back and forth are formed on both sides and the upper portion of the attachment portion 35.

<4. Attaching the drug container to the support>
Next, attachment of the medicine container 1 to the support 3 configured as described above will be described with reference to FIGS. 16 and 17 are side views showing attachment of the drug container to the support, and FIG. 18 is a perspective view of the support with the drug container attached. First, as shown in FIGS. 16 and 17, the neck portion 12 of the drug container 1 is inserted between the holding pieces 321 a and 321 b of the holding portion 32. Specifically, the inner edges of both holding pieces 321 a and 321 b are engaged with the gap between the protrusion 13 of the neck 12 and the upper surface 115 of the main body 11. In this state, the gap on the front end side of both holding pieces 321a and 321b is narrower than the diameter of the neck portion 12, so that this prevents the neck portion 12 from being detached from the holding portion 32. At this time, even if the cap 15 is not attached to the medicine container 1, it can be attached to the holding portion 32.

  Thus, when the neck portion 12 is attached to the holding portion 32, the medicine container 1 is suspended from the support 3. Therefore, the lower end edge of the support body 31 is arranged along the step 113 at the boundary between the first part 111 and the second part 112 on the back surface of the body part 11 of the medicine container 1. Therefore, when the medicine container 1 is attached to the support 3, the second portion 112 of the main body 11 of the medicine container 1 is disposed below the support body 31. At this time, the neck 12, the liquid absorbent core 2, and the cap 15 of the drug container 1 are disposed below the upper wall 34 of the support 3. Further, both sides of the main body part 11 of the medicine container 1 protrude slightly outward from both sides of the support main body 31.

<5. Cover member>
Next, the cover member 4 will be described with reference to FIGS. 19 is a front view of the cover member, FIG. 20 is a bottom view of FIG. 19, and FIG. 21 is a rear view of FIG. The cover member 4 is attached to the support 3, and forms an internal space that covers the upper part of the drug container 1 together with the support 3 when attached to the support 3. Details will be described below.

  As shown in FIGS. 19-21, the cover member 4 is provided with the front wall 41, the upper wall 42, and a pair of side wall 43, and is formed in the rectangular parallelepiped shape as a whole. And the space enclosed by these forms the internal space mentioned above. As shown in FIG. 20, each side wall 43 has a front part 431 connected to both sides of the front wall 41, a side part 432 extending rearward from both sides of the front part 431, and slightly from the rear end of the side part 432 in the left-right direction. And a rear portion 433 extending inward, and is formed in a U-shaped cross section as a whole. As shown in FIG. 1, the side portion 432 is formed with a plurality of through-holes 44 arranged in the vertical direction. These through-holes 44 communicate with the internal space and serve as vent holes as will be described later. .

  As shown in FIG. 21, the inner edge of the rear portion 433 of each side wall 43 and the rear end edge of the upper wall 42 are connected in a U-shape as viewed from the back to form an opening 45. On the other hand, the support body 31 of the support body 3 is fitted from below. Therefore, the inner edge of the rear part 433 in each side wall 43 and the rail 333 of the side wall 33 of the support 3 are engaged. Specifically, the rail 333 of the support 3 is engaged while sliding to the front side of the inner edge of the rear portion 433. Further, a concave portion 435 is formed at the upper end portion inside each side wall 43, and the protruding portion 334 of each side wall 33 of the support 3 is fitted into the concave portion 435.

<6. Installation of cover member>
Next, attachment of the cover member 4 to the support 3 configured as described above will be described with reference to FIGS. 22 to 25. 22 and 23 are a rear view and a front view showing attachment of the cover member to the support, FIG. 24 is a bottom view showing a state where the cover member is attached to the support, and FIG. 25 is a drug container, support, and cover. It is a rear view which shows the state by which the member was assembled.

  As shown in FIG. 22, the cover member 4 is attached from above the support 3. At this time, as shown in FIG. 23, the front side of the inner edge of the rear portion 433 of the cover member 4 slides along the back surface of the rail 333 of the support 3. Then, as shown in FIG. 24, when the upper end of the support body 31 of the support 3 comes into contact with the inner edge of the upper wall of the cover member 4, the slide is completed and the cover member 4 is attached to the support 3. . At this time, the protrusions 334 of the support 3 shown in FIG. 22 are snapped into the recesses 435 formed in the side walls 43 inside the cover member 4, and the cover member 4 is attached to the support 3. Fixed. Further, when the cover member 4 is sliding, the support piece 36 of the support body 3 and the upper edge portion 331 of the side wall 33 slide while abutting on the back surface of the front wall 41 of the cover member 4. Thereby, the front and rear positioning of the cover member 4 with respect to the support 3 is performed. In this state, the neck part 12 of the medicine container 1, the first part 111 of the main body part 11, and the liquid absorbent core 2 are covered with the cover member 4, and in particular, the liquid absorbent core 2 is prevented from contacting the outside.

<7. Fixed member>
Next, the fixing member 5 will be described with reference to FIG. FIG. 26 is a side view of the fixing member. As shown in FIG. 4, the fixing member 5 is formed so as to extend from the attachment portion 35 of the support body 31 to the back side. More specifically, the fixing member 5 includes a connecting portion 51 connected to the attachment portion 35, a plate-like first fixing piece 52 extending rearward from the connecting portion 51, and a lower side of the first fixing piece 52. And a plate-like second fixed piece 53 extending in parallel with the two. These are integrally formed. The connecting portion 51 includes a small-diameter shaft portion 511 and a circular retaining portion 512 that is attached to the front side of the shaft portion 511 and has a larger diameter than the shaft portion 511, and the shaft portion 511 is a through hole 351 of the attachment portion 35. Is attached through a notch 352. The inner diameter of the attachment portion 35 is substantially the same as that of the shaft portion 511, but is smaller than the retaining portion 512, so that the connecting portion 51 is attached around the shaft extending in the front-rear direction in the attachment portion 35. Further, since the minimum width D (see FIG. 14) of the notch 352 adjacent to the through hole 351 is smaller than the diameter of the shaft part 511, the notch 352 prevents the shaft part 511 from coming off.

  The first fixed piece 52 and the second fixed piece 53 can be elastically deformed with respect to the connecting portion 51, whereby both the fixed pieces 52 and 53 can be deformed so as to be close to each other. In the initial state, the rear end portions of the two fixing pieces 52 and 53 are in contact with each other, and the object to be attached is elastically placed between the two fixing pieces 52 and 53 by pushing it against the elastic force. It can be pinched.

<8. Usage of chemical volatilizer>
Next, the usage method of the chemical volatilizer comprised as mentioned above is demonstrated. First, from the state of FIG. 9, the cap 15 of the medicine container 1 is removed, and the liquid absorption core 2 is exposed. Subsequently, the drug container 1 with the cap 15 removed is attached to the support 3 as shown in FIG. That is, the neck portion 12 of the drug container 1 is inserted between the holding pieces 321 a and 321 b of the support 3. Specifically, the inner edges of both holding pieces 321 a and 321 b are engaged with the gap between the protrusion 13 of the neck 12 and the upper surface 115 of the main body 11. In this state, the gap on the front end side of both holding pieces 321a and 321b is narrower than the diameter of the neck portion 12, so that this prevents the neck portion 12 from being detached from the holding portion 32. The fixing member 5 is attached to the support 3 in advance.

  Thus, when the medicine container 1 is mounted, as shown in FIGS. 22 and 23, the cover member 4 is attached to the support while sliding from above. Subsequently, the fixing member 5 is attached to the attachment target portion. That is, the attachment object is sandwiched between the two fixing pieces 52 and 53 of the fixing member 5. Thus, the attachment of the chemical volatilizer is completed. In addition, although an attachment target object is not specifically limited, For example, it can be set as the air-conditioner of a motor vehicle, the exhaust port of a defroster, etc.

  Thereafter, the drug in the drug container 1 is sucked up by the liquid absorption core 2, and is evaporated to the outside of the drug container 1 through the liquid absorption core 2. That is, it evaporates from the plurality of vent holes 44 of the cover member 4 to the outside. Thereby, an aroma effect etc. can be acquired. In addition, when this chemical volatilizer is attached to an air conditioner of an automobile, for example, as shown in FIG. 4, air from the air conditioner flows from the back surface of the chemical volatilizer, that is, from a vent hole 316 formed in the support 3. , Flows into the interior space. Then, this air is discharged to the outside through a vent hole 44 formed on the side surface of the cover member 4. In this process, the medicine released from the liquid absorbent core 2 rides on the air flow of the air conditioner and is discharged from the vent hole 44 on the side surface of the cover member 4. Thereby, a chemical | medical agent can be spread in the vehicle with the air of an air conditioner, and an aroma effect can be acquired in the whole vehicle interior.

  Moreover, in the chemical | medical agent volatilizer which concerns on this embodiment, since the lower end of the liquid absorption core 2 is in contact with the bottom face of the chemical | medical agent container 1, a chemical | medical agent can be used up to the last.

  When the medicine is used up, the medicine container 1 needs to be replaced. In this case, the medicine container 1 can be replaced while the medicine volatilizer is attached to the attachment object. First, the cover member 4 is pulled up and removed from the support 3. Then, the exposed drug container 1 is pulled forward and removed from the support 3. At this time, both holding pieces 321 a and 321 b are pushed and expanded while being elastically deformed, and the neck portion 12 sandwiched between the holding pieces 321 a and 321 b is detached from the holding portion 32. Then, after attaching the new drug container 1 to the support 3 and then attaching the cover member 4 to the support 3, the replacement of the drug container 1 is completed.

<8. Features>
As described above, this embodiment has the following features.

<8-1>
Since the cover member 4 can be removed from the support 3 by sliding in a direction not toward the attachment object side, that is, upward, the cover member 4 interferes with the attachment object when the cover member 4 is slid. do not do. Therefore, the cover member 4 can be removed while the support 3 is attached to the attachment object. When the cover member 4 is removed, the medicine container 1 into which the liquid absorption core 2 is inserted appears and can be removed. Therefore, the medicine container 1 can be easily replaced while the support 3 is attached to the attachment object. can do.

<8-2>
Since the neck portion 12 of the medicine container 1 that contains the medicine is held by the holding portion 32 of the support 3 so as to be sandwiched from the left and right, even if the medicine container 1 is subjected to vibration from the lateral direction, The separation from the support can be prevented. As a result, the medicine can be prevented from spilling from the medicine container 1.

<8-3>
A protrusion 13 is formed on the outer peripheral surface of the neck 12, and the holding part 32 engages with a gap between the protrusion 13 and the upper surface 115 of the main body 11, so that the movement of the drug container 1 in the vertical direction is restricted. Is done. Therefore, it is possible to prevent the medicine container 1 from being detached from the support body 3 even when the medicine container 1 receives vertical vibrations.

<8-4>
The main body part 11 of the medicine container 1 includes a first part 111 connected to the neck part 12 and a second part 112 connected to the lower end part of the first part 111 and having a larger outer shape than the first part 111. Therefore, the volume of the medicine container 1 can be increased without increasing the main body 11 in the height direction.

  Further, since the drug container 1 is attached to the support 3 so that the second portion 112 protrudes from the lower side of the cover member 4, the vicinity of the bottom of the drug container 1 can be exposed from the cover member 4. it can. Thereby, the remaining amount of the medicine can be visually recognized until the medicine is used up. Moreover, since the width in the left-right direction of the cover member 4 and the width in the left-right direction of the second portion 112 of the medicine container 1 are substantially the same, the design can be performed even if the second portion 112 protrudes from the lower side of the cover member 4. You can have a sense of unity.

<9. Modification>
As mentioned above, although one Embodiment of this invention was described, this invention is not limited to this, A various change is possible unless it deviates from the meaning. The following modifications can be combined as appropriate.

<9-1>
In the above embodiment, the cover member 4 can be slid in the vertical direction and can be detached from the support body 3 by sliding upward, but the present invention is not limited to this. In other words, any direction that does not face the object to be attached may be slid in any direction so that it can be detached from the support 3.

<9-2>
The configuration of the cover member 4 is not particularly limited, and may be configured to cover at least the liquid absorbent core so that the user does not contact the liquid absorbent core 2.

<9-3>
In the above embodiment, the holding portion 32 is engaged between the protrusion 13 of the neck portion 12 and the upper surface 115 of the main body portion 11, but is not limited to this. That is, the holding portion 32 can be engaged using the male screw 14 provided on the neck portion 12. Further, the protruding portion 13 of the neck portion 12 does not need to be provided over the entire circumference of the neck portion 12 and may be a part. Furthermore, a plurality of protrusions 13 may be provided in the axial direction of the neck 12, and the holding part 32 may be engaged between the adjacent protrusions 13.

  The form of the holding portion 32 is not particularly limited, and is not particularly limited as long as the holding portion 32 is held so as to sandwich the neck portion 12 from the radially outer side of the neck portion 12. Moreover, it is not restricted to the neck part 12, It can also hold | maintain so that the main-body part 11 may be pinched | interposed from radial direction outer side.

<9-4>
The form of the support 3 is not particularly limited as long as it is configured so that at least the holding portion 32 is provided and the cover member 4 can be attached and detached.

<9-5>
The shaft portion 511 of the connecting portion 51 can be formed in a polygonal shape so that each side engages with the through hole 351 of the attachment portion 315. Thereby, when the connection part 51 rotates, the connection part 51 can be fixed with respect to the attachment part 315 every predetermined angle, and a chemical volatilizer is fixed to a desired angle with respect to an attachment target object. Can do. Or you may make it the connection part 51 of the fixing member 5 rotate with respect to the attachment part 315 almost without resistance. Thereby, for example, when the support body 3 receives vibration, the support body 3 can rotate with respect to the fixing member 5.

  The form of the fixing member 5 is not particularly limited as long as it can be fixed to the attachment target. In addition, the support 3 can be directly fixed to the attachment object with a double-sided tape or the like without providing the fixing member 5.

<9-6>
The form of the medicine container 1 is not particularly limited as long as the medicine container 1 has an opening 121 at least at the top, and the liquid absorbent core 2 can be inserted so as to be impregnated with the medicine from the opening 121. Accordingly, the shape, material, etc. are not particularly limited.

<9-7>
At least one of the groove 122 formed in the opening 121 of the neck portion 12 of the drug container 1 and the groove 21 of the liquid absorbent core 2 is sufficient. Therefore, only the opening groove of the neck 12 or only the groove 21 of the liquid absorbent core 2 may be provided.

DESCRIPTION OF SYMBOLS 1: Drug container 11: Main-body part 12: Neck part 121: Opening 13: Projection part 2: Liquid absorption core 3: Support body 31: Support main body 32: Holding part 4: Cover member 5: Fixing member

Claims (9)

A drug container having an opening at the top and containing a liquid drug;
A liquid absorbent core to be inserted into the opening of the drug container;
Supporting the drug container, and a support attached to the attachment object;
A cover member that is detachably attached to the support and covers at least the liquid-absorbing core;
With
The chemical vaporizer, wherein the cover member is configured to be removed from the support by sliding in a direction not facing the attachment object. The drug container is attached to the support on the side opposite to the attachment object across the support,
The drug volatilizer according to claim 1, wherein the cover member is configured to slide in a direction orthogonal to a direction from the attachment object toward the drug container.   The said cover member is formed so that at least one part of the said liquid absorption core and the said chemical | medical agent container may be covered, and it is comprised so that it may detach | leave from the said support body by sliding upwards. The chemical volatilizer described in 1.   4. The drug volatilizer according to claim 1, wherein the support includes a holding unit that holds the drug container so as to sandwich the drug container from outside in a radial direction with respect to the axial direction of the opening. The drug container includes a neck part in which the opening is formed, and a main body part having an outer shape larger than the neck part and connected to the neck part,
The drug volatilizer according to claim 4, wherein the holding part is configured to hold the neck part.   The said main-body part is equipped with the 1st site | part connected with the said neck part, and the 2nd site | part connected with the lower end part of the said 1st site | part, and a larger external shape than the said 1st site | part, The chemical volatilizer as described.   The drug volatilizer according to claim 6, wherein the second part of the drug container is attached to the support so as to protrude from a lower side of the cover member. The support and the cover member form an internal space in which at least the liquid absorption core is accommodated,
The drug volatilizer according to any one of claims 1 to 7, wherein at least one vent hole communicating with the internal space is formed in at least one of the cover member and the support. A plurality of the vent holes are formed;
The drug volatilizer according to claim 8, wherein at least one of the vent holes is formed at a position facing the attachment object in the support.

Images